1-9 of 9
Loïc Ysebaert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Clinical Trials & Observations
Hervé Ghesquières, Fanny Cherblanc, Aurélien Belot, Sophie Micon, Krimo K. Bouabdallah, Cyril Esnault, Luc-Matthieu Fornecker, Katia Thokagevistk, Maxime Bonjour, Fontanet Bijou, Corinne Haioun, Nadine Morineau, Loïc Ysebaert, Gandhi Damaj, Benoit Tessoulin, Stéphanie Guidez, Franck Morschhauser, Catherine Thiéblemont, Adrien Chauchet, Rémy Gressin, Fabrice Jardin, Christophe Fruchart, Gaëlle Labouré, Ludovic Fouillet, Pauline Lionne-Huyghe, Antoine Bonnet, Laure Lebras, Sandy Amorim, Cécile Leyronnas, Gaelle Olivier, Romain Guieze, Roch Houot, Vincent Launay, Bernard Drénou, Olivier Fitoussi, Laurence Detourmignies, Julie Abraham, Carole Soussain, Florence Lachenal, Gian Matteo Pica, Patrick Fogarty, Pascale Cony-Makhoul, Adeline Bernier, Sandra Le Guyader-Peyrou, Alain Monnereau, Frédéric Boissard, Cédric Rossi, Vincent Camus
Journal: Blood Advances
Blood Adv (2024) 8 (2): 296–308.
https://doi.org/10.1182/bloodadvances.2023010798
Published: 2024
Includes: Supplemental data
Journal Articles

A fixed-duration immunochemotherapy approach in CLL: 5.5-year results from the phase 2 ICLL-07 FILO trial

Clinical Trials & Observations
Anne-Sophie Michallet, Rémi Letestu, Magali Le Garff-Tavernier, Lydia Campos, Michel Ticchioni, Marie-Sarah Dilhuydy, Stephane Morisset, Valérie Rouille, Béatrice Mahé, Kamel Laribi, Bruno Villemagne, Emmanuelle Ferrant, Olivier Tournilhac, Alain Delmer, Lysiane Molina, Véronique Leblond, Cécile Tomowiak, Sophie de Guibert, Frederique Orsini-Piocelle, Anne Banos, Philippe Carassou, Guillaume Cartron, Luc Mathieu Fornecker, Loic Ysebaert, Caroline Dartigeas, Margot Truchan-Graczyk, Jean-Pierre Vilque, Thérèse Aurran Schleinitz, Florence Cymbalista, Stéphane Leprêtre, Vincent Lévy, Florence Nguyen-Khac, Pierre Feugier
Journal: Blood Advances
Blood Adv (2023) 7 (15): 3936–3945.
https://doi.org/10.1182/bloodadvances.2022009594
Published: 2023
Includes: Supplemental data
Journal Articles

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa, Rene Oliver Casasnovas, Clio Baillet, Emmanuel Bachy, Emmanuelle Nicolas-Virelizier, Jean Marc Schiano De colella, Clement Bailly, Salim Kanoun, Stéphanie Guidez, Emmanuel Gyan, Remy Gressin, Nadine Morineau, Loic Ysebaert, Steven Le Gouill, Herve Tilly, Roch Houot, F. Morschhauser, Guillaume Cartron, Charles Herbaux
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3735–3738.
https://doi.org/10.1182/bloodadvances.2023009911
Published: 2023
Includes: Supplemental data
Journal Articles

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Silvia Bonfiglio, Lesley-Ann Sutton, Viktor Ljungström, Antonella Capasso, Tatjana Pandzic, Simone Weström, Hassan Foroughi-Asl, Aron Skaftason, Anna Gellerbring, Anna Lyander, Francesca Gandini, Gianluca Gaidano, Livio Trentin, Lisa Bonello, Gianluigi Reda, Csaba Bödör, Niki Stavroyianni, Constantine S. Tam, Roberto Marasca, Francesco Forconi, Panayiotis Panayiotidis, Ingo Ringshausen, Ozren Jaksic, Anna Maria Frustaci, Sunil Iyengar, Marta Coscia, Stephen P. Mulligan, Loïc Ysebaert, Vladimir Strugov, Carolina Pavlovsky, Renata Walewska, Anders Österborg, Diego Cortese, Pamela Ranghetti, Panagiotis Baliakas, Kostas Stamatopoulos, Lydia Scarfò, Richard Rosenquist, Paolo Ghia
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2794–2806.
https://doi.org/10.1182/bloodadvances.2022008821
Published: 2023
Includes: Supplemental data
Journal Articles

International consensus statement on the management of cardiovascular risk of Bruton’s tyrosine kinase inhibitors in CLL

Farrukh T. Awan, Daniel Addison, Feras Alfraih, Sergio J. Baratta, Rodrigo Noronha Campos, María Silvana Cugliari, Yeow Tee Goh, Valery Alexandrovich Ionin, Stefanie Mundnich, Aaron L. Sverdlov, Constantine Tam, Loïc Ysebaert
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5516–5525.
https://doi.org/10.1182/bloodadvances.2022007938
Published: 2022
Includes: Supplemental data
Journal Articles

Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS

Charlotte Syrykh, Pauline Gorez, Sarah Péricart, David Grand, Frédéric Escudié, Bastien Cabarrou, Lucie Obéric, Loïc Ysebaert, Laurence Lamant, Camille Laurent, Solène M. Evrard, Pierre Brousset
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4590–4593.
https://doi.org/10.1182/bloodadvances.2021005249
Published: 2021
Includes: Supplemental data
Journal Articles

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Maud D'Aveni-Piney, Lucie Obéric, Caroline Bodet-Milin, Pierre Bories, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Eugenio Galli, Sophie Bernard, Marie-Thérèse Rubio, Celine Bossard, Veronique Meignin, Pascal Merlet, Pierre Feugier, Steven Le Gouill, Loic Ysebaert, Olivier Casasnovas, Michel Meignan, Sylvie Chevret, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5607–5615.
https://doi.org/10.1182/bloodadvances.2020003001
Published: 2020
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data
Journal Articles

Onsets of progression and second treatment determine survival of patients with symptomatic Waldenström macroglobulinemia

Clinical Trials & Observations
Stephanie Guidez, Julien Labreuche, Elodie Drumez, Loic Ysebaert, Jana Bakala, Caroline Delette, Bénédicte Hivert, Caroline Protin, Hervé Declercq, Mélanie Verlay, Jean Pierre Marolleau, Alain Duhamel, Pierre Morel
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3102–3111.
https://doi.org/10.1182/bloodadvances.2018021287
Published: 2018
Includes: Supplemental data